Related Experiment Video
Updated: Sep 25, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Intrinsic role of chaperone-mediated autophagy in cancer stem cell maintenance
Jaione Auzmendi-Iriarte1, Ander Matheu1,2,3
1Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.
Abstract:
Chaperone-mediated autophagy (CMA) is a selective type of autophagy specialized in the individual degradation of targeted proteins. Its impact in any cancer stem cell (CSC) subtype remained elusive. In a recent study, we characterized the expression of LAMP2A and CMA activity in glioblastoma revealing its enrichment in a glioma stem cell (GSC) subpopulation. LAMP2A downregulation diminishes proliferation and self-renewal and induces apoptosis in GSCs in vitro, whereas it delays tumor progression in vivo. The underlying molecular signature of CMA comprises several proteomic and transcriptomic pathways with special relevance to mitochondrial function, the interferon pathway and extracellular matrix interactions. Remarkably, these activities are translated into the clinical scenario, as glioblastoma (GBM) samples show increased expression of LAMP2 compared to healthy tissue, with this expression being positively associated with malignancy grade, TMZ resistance and lower patient survival. These results reveal a novel function of CMA as an intrinsic regulator of GSC tumorigenic properties and highlight its relevance in GBM progression.
Insights
Chaperone-mediated autophagy (CMA) regulates glioblastoma stem cells. Inhibiting CMA reduces tumor growth and improves patient survival, revealing CMA as a therapeutic target in brain cancer.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Chaperone-mediated autophagy (CMA) is a selective protein degradation pathway.
- The role of CMA in cancer stem cells (CSCs), particularly in glioblastoma, was previously unclear.
Purpose of the Study:
- To investigate the expression and activity of CMA in glioblastoma stem cells (GSCs).
- To determine the functional impact of CMA modulation on GSC behavior and glioblastoma progression.
Main Methods:
- Characterization of LAMP2A expression and CMA activity in GSCs.
- In vitro and in vivo experiments involving LAMP2A downregulation.
- Proteomic and transcriptomic analyses to identify CMA-associated molecular pathways.
- Correlation analysis of LAMP2 expression with clinical parameters in glioblastoma patients.
Main Results:
- CMA is enriched in a subpopulation of GSCs.
- Downregulation of LAMP2A (a key CMA component) inhibits GSC proliferation and self-renewal, induces apoptosis, and delays tumor progression in vivo.
- CMA's molecular signature involves mitochondrial function, interferon pathways, and extracellular matrix interactions.
- Increased LAMP2 expression in glioblastoma correlates with higher malignancy grade, temozolomide resistance, and poorer patient survival.
Conclusions:
- CMA plays a critical role in regulating GSC tumorigenic properties.
- CMA represents a novel therapeutic target for glioblastoma, with implications for improving patient outcomes.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

